Pfizer Reaches $93M Deal With Lipitor Buyers In Antitrust MDL
Pfizer Inc. has agreed to shell out $93 million to put to rest Lipitor buyers' claims in sprawling antitrust multidistrict litigation over the cholesterol medication that stretches back more than a...To view the full article, register now.
Already a subscriber? Click here to view full article